Dudediligence.

Tango Therapeutics, Inc

TNGXNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$175.3M

10 notices · 6,368,941 sh

Oct 2025 to Oct 2026

Reported ·

$9,536,543

16 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

9 of 16 reported sales carry the 10b5-1 box. Together they are 0.44% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-22: Jessica Newcomb, Form 1442026-08-03: ADAM CRYSTAL, Form 1442026-06-17: Nextech Crossover I SCSp, Form 1442026-06-11: DANIELLA BECKMAN, Form 1442026-06-10: DANIELLA BECKMAN, Form 1442026-05-01: ADAM CRYSTAL, Form 1442026-03-25: ADAM CRYSTAL, Form 1442026-03-05: ADAM CRYSTAL, Form 1442026-02-25: ADAM CRYSTAL, Form 1442025-10-23: Third Rock Ventures IV, L.P., Form 1442025-10-23: TRV GP IV, LLC, sold2026-02-03: Crystal Adam, sold2026-02-03: Weber Barbara, sold2026-02-03: Beckman Daniella, sold2026-02-25: Crystal Adam, sold2026-03-05: Crystal Adam, sold2026-03-25: Crystal Adam, sold2026-04-01: Crystal Adam, sold2026-04-15: Crystal Adam, sold2026-05-01: Crystal Adam, sold2026-06-01: Crystal Adam, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-09-22Jessica Newcomb, Principal Accounting Officer$340,108
15,231 shplan 2026-06-23Form 4s on file end Jun 23144 ↗
2026-08-03ADAM CRYSTAL, President, R&D$2,201,580
81,000 shplan 2025-10-27Form 4s on file end Jun 23144 ↗
2026-06-17Nextech Crossover I SCSp, Former Affiliate$113.4M
3,766,081 shno plan dateForm 4s on file end Jun 23144 ↗
2026-06-11DANIELLA BECKMAN, Chief Financial Officer$51.5M
1,791,726 shno plan dateForm 4s on file end Jun 23144 ↗
2026-06-10DANIELLA BECKMAN, Chief Financial Officer$133,380
4,446 shno plan dateForm 4s on file end Jun 23144 ↗
2026-05-01ADAM CRYSTAL, President, R&D$1,415,245
65,460 shplan 2025-10-27144 ↗
Form 4, 2026-05-05: sold 27,000 at $21.22 Form 4 ↗
2026-03-25ADAM CRYSTAL, President, R&D$1,811,640
93,000 shplan 2025-10-27144 ↗
Form 4, 2026-03-27: sold 12,000 at $20.11 Form 4 ↗
2026-03-05ADAM CRYSTAL, President, R&D$250,100
20,251 shplan 2025-10-27144 ↗
Form 4, 2026-03-09: sold 20,251 at $15.00 Form 4 ↗
2026-02-25ADAM CRYSTAL, President, R&D$699,964
54,345 shplan 2025-10-27144 ↗
Form 4, 2026-02-27: sold 54,345 at $12.77 Form 4 ↗
2025-10-23Third Rock Ventures IV, L.P., 10% Stockholder$3,594,830
477,401 shno plan date144 ↗
Form 4, 2025-10-27: sold 477,401 at $10.15 Form 4 ↗